Company Profile

EraGen Biosciences Inc (AKA: Sulfonics, Inc.~Eragen Biosciences Inc~Somatocor Inc)
Profile last edited on: 4/5/19      CAGE: 1V8J6      UEI:

Business Identifier: Molecular reagent products and software for diagnostics and research
Year Founded
1999
First Award
1999
Latest Award
2005
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

918 Deming Way Suite 201
Madison, WI 53717
   (608) 662-9000
   info@eragen.com
   www.eragen.com
Location: Multiple
Congr. District: 02
County: Dane

Public Profile

In 2011, EraGen was acquired by Luminex Corporation. EraGen Biosciences, Inc., a biotechnology company, develops, manufactures, and markets molecular reagent products and software for research and clinical testing markets. The company offers molecular diagnostic assays for the early detection and monitoring of cancer, genetic, and infectious diseases, as well as for genetic-based conditions. Its products include molecular diagnostic tests, analyte specific reagents, in vitro diagnostic reagents, and research use only reagents; MultiCode-PLx Analysis Software that allows users to create customized templates for plate and assay layouts; and MultiCode-RTx Analysis Software, which enables users to create templates for quantitative and qualitative analyses. The company serves clinical laboratories and medical researchers. It sells its products through distributors in the United States and Canada. The company was founded in CA as Sulfonics, Inc. in 1994 and when moved to Wisconsin changed its name to EraGen Biosciences, Inc. in 1999.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
50-74
Revenue Range
5M-7.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
15-19

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2005 2 NIH $850,000
Project Title: Nonpeptide Somatostatin Agonists for Retinopathy
2004 1 NIH $99,802
Project Title: 6 Base PCR to Build a Superior Genetic Detection System
2004 1 NIH $350,248
Project Title: Detecting Early Emerging Drug-Resistant HIV Populations
2004 1 NIH $325,712
Project Title: Rapid Detection of Agents that Cause Respiratory Disease
2004 1 NIH $100,000
Project Title: Pharmacophylogenomic Dates for the Master Catalog

Key People / Management

  Irene Hrusovsky -- President

  Stephen G Chamberlin

  Linda Pauls Fleming -- Chief Financial Officer

  Mary E Holland -- Vice President, Sales and Marketing

  Tang Li

  James R Prudent -- former President

  Prem L Sharma

Company News

There are no news available.